Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.

Mihir Gandhi Wen-Huan Ling Chien-Hung ChenJoon Hyeok LeeMasatoshi KudoRawisak ChanwatSimone Irene StrasserZhu XuSoh-Han LaiPierce Kah-Hoe Chow

Published in: Journal of hepatocellular carcinoma (2021)

The COVID-19 pandemic has significantly impacted the management of HCC among Asia-Pacific countries. The impact varies according to the disease stage and country. Well thought-through long-term strategies are required to ameliorate the negative impact of the pandemic on HCC patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
respiratory syndrome coronavirus